Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04435808 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19
A Phase 1 study, sponsored by University of New Mexico.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT04435808: Clinical Trial Phase 1 study, sponsored by University of New Mexico.
NCT04435808 is a Phase 1 study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04435808, a Phase 1 study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The HCW Prophylaxis (HCWP) Study, single, open and off label intervention study. Up to 350 participants will be assigned to group that takes HCQ or group that opts to not take study medication. Participants will be UNM HEALTH SYSTEM HCW at high risk for occupational exposure to SARSCoV- 2. Study timepoints will include Day 1 screening/enrollment, 30 day, 60 day, and 90 day assessments. Questionnaires will be collected in all timepoints.
Primary Outcome
Number of health care workers who become infected with SARS-CoV-2 as detected by PCR
Interventions
- DRUG Hydroxychloroquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-04-14 |
| Est. Completion | 2020-07-15 |
| Phase | Phase 1 |
Why NCT04435808 stopped before completion
NCT04435808 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Hydroxychloroquine is the first listed.
NCT04435808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04435808 about?
NCT04435808 is a clinical study titled "Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19". The HCW Prophylaxis (HCWP) Study, single, open and off label intervention study. Up to 350 participants will be assigned to group that takes HCQ or group that opts to not take study medication. Participants will be UNM HEALTH SYSTEM HCW at high risk for occupational exposure to SARSCoV- 2. Study tim...
What is the current status of trial NCT04435808?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2020-04-14. Estimated completion is 2020-07-15.
What interventions are being tested in trial NCT04435808?
The interventions under investigation include: Hydroxychloroquine (DRUG).
Who is sponsoring clinical trial NCT04435808?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04435808's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI